(Updated, 8/5/14, 9:10 am ET) Enumeral Biomedical started up a few years ago around a new way to help scientists measure how the body responds to infection and disease. Today, with a few partnerships and in-house drug candidates under its belt, the Cambridge, MA, and New York-based startup is heading into the public markets to … Continue reading “Enumeral Raises $21.5M, Heads to the OTC Via Reverse Merger”
Tag: Cellectar Biosciences
Cellectar, an OTC Stock, Eyes Nasdaq Jump to Boost Profile, Prospects
Cellectar Biosciences is trying to move from an over-the-counter (OTC) stock to trading on the Nasdaq stock exchange—and the stakes are high for the small Madison, WI-based biotech. Winning approval to join the Nasdaq stock exchange could give Cellectar a boost in bringing its cancer drugs and imaging products to market—assuming the company can capitalize … Continue reading “Cellectar, an OTC Stock, Eyes Nasdaq Jump to Boost Profile, Prospects”
Wisconsin Roundup: Wellbe, Kiio, Cellectar, RideScout, & More
Two Madison startups are raising more capital. Madison-based biotech Cellectar Biosciences intends to trade on the Nasdaq stock exchange. RideScout has entered the Wisconsin market. And Milwaukee-area electric car drivers have new charging stations. Read on for a breakdown of last week’s Wisconsin innovation and tech news. —Madison-based Wellbe has raised $425,000 in a debt … Continue reading “Wisconsin Roundup: Wellbe, Kiio, Cellectar, RideScout, & More”
Novelos Becomes Cellectar, Returns to Madison Roots
Novelos Therapeutics today announced a corporate name change that returns to the roots of the Madison, WI, company. Novelos (OTCQX: [[ticker:NVLT]]) is now Cellectar Biosciences and will trade under the stock ticker symbol (OTCQX: [[ticker:CLRB]]) effective Wednesday. The new name should be familiar to those who follow Wisconsin’s life sciences industry. Novelos was formerly based … Continue reading “Novelos Becomes Cellectar, Returns to Madison Roots”